Company: SMNR
Filing Date: 2025-07-23
Form Type: S-4/A
Source: 0001193125-25-163401
Chunk: 625

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: S-4/A
Chunk 625
---
 Followwill will qualify as an audit committee financial expert within the meaning of SEC regulations and each of Jay Chun, M.D., Ph.D., Dorman Followwill and Yue Alexander Wu, Ph.D. will meet the financial sophistication requirements under the Nasdaq Listing Rules. New Semnur’s independent registered public accounting firm and New Semnur management will periodically meet separately with the audit committee. The audit committee will review, discuss and assess its own performance and composition at least annually. The audit committee will also periodically review and assesses the adequacy of its charter, including its role and responsibilities as outlined in its charter, and recommend any proposed changes to the New Semnur Board for its consideration and approval. The composition and functioning of the audit committee will comply with all applicable requirements of the Sarbanes-Oxley Act and all applicable SEC rules and Nasdaq Listing Rules. New Semnur intends to comply with future requirements to the extent they become applicable to New Semnur. Compensation Committee New Semnur’s compensation committee will consist of Dorman Followwill and Yue Alexander Wu, Ph.D., with Yue Alexander Wu, Ph.D. serving as the chairperson of the committee. Dorman Followwill and Yue Alexander Wu, Ph.D. will each satisfy the independence requirements under the Nasdaq Listing Rules. Each of the members of the compensation committee will be a non-employeedirector as defined in Rule 16b-3promulgated under the Exchange Act and will satisfy Nasdaq independence requirements. The compensation committee will act on behalf of the New Semnur Board to fulfill the New Semnur Board’s responsibilities in overseeing the company’s compensation policies, plans and programs; and in reviewing and determining the compensation to be paid to the executive officers and non-employeedirectors of New Semnur. The responsibilities of the compensation committee are included in its written charter. The compensation committee’s responsibilities will include, among others:

| • |     | reviewing, modifying and approving (or, if it deems appropriate, making recommendations to the New Semnur Board regarding) New Semnur’s overall compensation strategy and policies, to assure that they promote stockholder interests and support the Company’s strategic and tactical objectives, and that they provide for appropriate rewards and incentives for the Company’s management and employees; |

| • |     | reviewing, modifying and approving corporate performance goals and objectives relevant to the compensation of New Semnur’s executive officers and other senior management; |

| • |     | determining and approving (or,